3Maniotis A J,Folberg R,Hess A,et al.Vascular channel formation by human melanoma cells in vivo and invitro:vasculogenic mimicry[J].Am Pathol,1999,155(3):739-752.
6Casali PG, Jost L, Reichardt P, et al. Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol, 2009, 20 Suppl 4:64-67.
7Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 2002, 33(5):459-465.
8Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol, 2005, 29( 1 ) : 52-68.
9Miettinen M, Lasota J. KIT ( CD117 ) : a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol, 2005, 13 (3) :205-220.
10Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol, 2004, 22(18) : 3813-3825.
6Jiang R,Zatta A,Kin H,et al. PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in vivo rat hearts[J]. Am J Physiol Heart Circ Physiol, 2007,293 (5) : 2845-2852.
7Caruso R,Pallone F, Fina D, et al. Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth, factor receptor trans-activation and proliferation [J]. Am J Pathol, 2006,169 (1) : 268-278.
8Jahan I, Fuiimoto J, Alam SM, et al. Role of protease activated receptor-2 in tumor Advancement of ovarian cancers[J]. Annals Oncol, 2007,18(9) : 1506-1512.
9Sanchez-Hernandez PE, Ramirez-Duenas MG, Albarran-Somoza B, et al. Protease-activated receptor-2 (PAR-2) in cervical cancer prolifer ation[J]. Gynecol Oncol, 2008,108 (1) : 19-26.
10Jahan I, Fujimoto J,Alam SM,et al. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers [J]. BMC Cancer,2008,8(10):301-308.
